Finance

Lists
CANF:NYSEAMERICAN
Can Fite Biopharma ADR Representing 300 Ord Shs
$2.16
-1.37%
(-0.030) 1D
$2.18
+0.93% (+0.020)
After hours
Closed: Sep 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CANF...
Open
$2.22
High
$2.23
Low
$2.16
Mkt. cap
20.71M
Avg. vol.
728.84K
Volume
0.00
52-wk high
$13.40
52-wk low
$2.16
Beta
1.12
Shares outstanding
3.03M
No. of employees
5
Open
$2.22
High
$2.23
Low
$2.16
Mkt. cap
20.71M
Avg. vol.
728.84K
Volume
0.00
52-wk high
$13.40
52-wk low
$2.16
Beta
1.12
Shares outstanding
3.03M
No. of employees
5
News stories
From web sources and news partners
About Can Fite Biopharma ADR Representing 300 Ord Shs
CEO-
Employees5
Founded1994
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
101.50K
101.50K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.83M
1.83M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
798.00K
798.00K
-
-
Operating expense
2.63M
2.63M
-
-
Total operating expenses
2.63M
2.63M
-
-
Operating income
-2.53M
-2.53M
-
-
Other non operating income
-7.00K
-7.00K
-
-
EBT including unusual items
-2.48M
-2.48M
-
-
EBT excluding unusual items
-2.47M
-2.47M
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.48M
-2.48M
-
-
Net profit margin
-2,439.41%
-2,439.41%
-
-
Earnings per share
-
-
-
-
Interest and investment income
131.00K
131.00K
-
-
Interest expense
-
-
-
-
Net interest expenses
131.00K
131.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.53M
-2.53M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps